IMC 2.33% 8.8¢ immuron limited

Regarding trial NCT06122870 my opinion only.The trial outcome...

  1. 430 Posts.
    lightbulb Created with Sketch. 85
    Regarding trial NCT06122870 my opinion only.

    The trial outcome will give a very early indication of the compounds efficacy 9very small cohort), I may be wrong but for my memory the only early data received re. efficacy against Campylobacter was via western blot analysis back in early 2017.

    So the short answer is no, I don't believe the Campylobacter trial outcomes would cause the curtains to come down on the DoD collaborations. But thanks for the question , happy to hear others opinions.
 
watchlist Created with Sketch. Add IMC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.